SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Bought by Commonwealth Equity Services LLC

Commonwealth Equity Services LLC grew its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 34.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 152,430 shares of the exchange traded fund’s stock after purchasing an additional 39,190 shares during the quarter. Commonwealth Equity Services LLC owned approximately 0.20% of SPDR S&P Biotech ETF worth $13,728,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of XBI. Healthcare of Ontario Pension Plan Trust Fund lifted its stake in SPDR S&P Biotech ETF by 198.6% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock valued at $911,825,000 after buying an additional 6,138,000 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd acquired a new stake in shares of SPDR S&P Biotech ETF in the third quarter worth approximately $141,284,000. Proficio Capital Partners LLC increased its position in shares of SPDR S&P Biotech ETF by 16,156.1% during the fourth quarter. Proficio Capital Partners LLC now owns 917,329 shares of the exchange traded fund’s stock worth $82,615,000 after purchasing an additional 911,686 shares in the last quarter. Raymond James Financial Inc. acquired a new position in SPDR S&P Biotech ETF in the 4th quarter valued at $55,529,000. Finally, J.Safra Asset Management Corp lifted its holdings in SPDR S&P Biotech ETF by 461.6% in the 4th quarter. J.Safra Asset Management Corp now owns 292,502 shares of the exchange traded fund’s stock valued at $26,293,000 after purchasing an additional 240,415 shares in the last quarter.

SPDR S&P Biotech ETF Stock Up 1.3 %

SPDR S&P Biotech ETF stock opened at $88.29 on Tuesday. The company has a fifty day simple moving average of $89.98 and a 200-day simple moving average of $94.69. The firm has a market capitalization of $5.72 billion, a price-to-earnings ratio of 11.47 and a beta of 0.99. SPDR S&P Biotech ETF has a 52-week low of $81.14 and a 52-week high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.